[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

[Asia Economy Reporter Yu Je-hoon] Hong Kong authorities announced on the 3rd, according to RTHK, that starting from the 11th, additional COVID-19 vaccinations will be administered to high-risk groups such as immunocompromised individuals and those aged 60 and above.


According to the report, cancer patients, organ transplant recipients, and AIDS patients can receive the additional dose within 4 weeks after their second vaccination, while healthcare workers, airport and hotel staff, and those aged 60 and above can receive it after 6 months.


Experts from the Hong Kong government advised that citizens can choose the Sinovac vaccine for the additional dose, but recommended selecting the Pfizer vaccine for better immune response.



The issue lies in the vaccine supply. The Hong Kong government estimates that about 1.86 million people are included in the priority group for this additional vaccination, but the secured vaccine quantity is only about 1.7 million doses. Sophia Chan, Hong Kong Secretary for Food and Health, stated, "Currently, the stock is sufficient, but we will monitor the situation. If there is a shortage, we will procure enough vaccines for those in need."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing